Our News
Discover the latest news from the Transformative Rare Cancer Initiative

Fred Hutch study dramatically expands therapeutic range of approved kinase drugs
Comprehensive analysis reveals new uses for existing therapies across cancer types and other diseases

Fred Hutch brings together rare cancer community
Patients, families and researchers at TRACER symposium share experiences, explore the science behind rare cancers and drive progress through collaboration.

Showcasing new strides in rare cancer research
Local and national experts in areas such as immunotherapy, clinical trial design and biobanking gathered to spotlight breakthroughs in rare cancer research.

Are Tissue-Agnostic Oncology Drugs a Silver Bullet for Rare Cancers?
TRACER’s director shares how treatments guided by tumor biology — not location — could reshape care for patients with rare cancers.

Fred Hutch study finds new life for ‘ineffective’ drugs
Testing drugs on thin tumor slices, not just cancer cells in a Petri dish, reveals untapped potential for treating rare cancers.

A new partnership aims to advance rare cancer research — with patients’ help
A coast-to-coast collaboration between TRACER and RCRF aims to turn patient-donated tumors into AI-powered insights on rare cancers.

Rare cancer researchers find promising target in fibrolamellar cancer
Fred Hutch’s TRACER initiative digs into aggressive liver cancer, hosts third rare cancer symposium.

Oncologists Turn to Off-Label Drug Use for Rare Cancers: What to Know
TRACER’s director explains why off-label prescribing — guided by tumor biology — is becoming a vital and proactive strategy for rare cancers.

Every Oncologist Can Help Transform Rare Cancer Care
TRACER’s director shares how, with just a few small steps, oncologists can help shape the future of rare cancer treatment.

Rare cancer researchers at TRACER symposium set sights on treatments stalled by red tape
Cures for rare cancers are hiding in plain sight — they just need help actually getting to the people who need them.

Oncologists Can Help Turn the Tide Against Rare Cancers With New Initiative
TRACER’s director shares how clinicians can help accelerate rare cancer research.

The power of the pack: New rare cancer initiative hopes collaboration will lead to cures
Rare cancers can leave patients, families and scientists feeling isolated — but a growing community is showing how connection can drive progress.

TRACER Team Receives Funding from Brave Like Gabe Foundation to Support Rare Cancer Research
The TRACER team is thrilled to receive the generous support of the Brave Like Gabe Foundation. The Brave Like Gabe Foundation was founded by the

TRACER Initiative Launches Rare Cancer Research Symposium
March 28, 2024. The inaugural Rare Cancer Research Symposium, held on March 27th, immediately following the launch of the TRACER initiative, was met with resounding

Fred Hutch launches rare cancer research effort
New TRACER initiative aims to accelerate advances through multidisciplinary collaboration and innovative approaches Fred Hutch’s Dr. Taran Gujral just launched TRACER, the Transformative Rare Cancer